Current Understanding of Human Enterovirus D68
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Human enterovirus D68 (EV-D68), a member of the species Enterovirus D of the Picornaviridae family, was first isolated in 1962 in the United States. EV-D68 infection was only infrequently reported until an outbreak occurred in 2014 in the US; since then, it has continued to increase worldwide. EV-D68 infection leads to severe respiratory illness and has recently been reported to be linked to the development of the neurogenic disease known as acute flaccid myelitis (AFM), mostly in children, seriously endangering public health. Hitherto, treatment options for EV-D68 infections were limited to supportive care, and as yet there are no approved, specific antiviral drugs or vaccines. Research on EV-D68 has mainly focused on its epidemiology, and its virologic characteristics and pathogenesis still need to be further explored. Here, we provide an overview of current research on EV-D68, including the genotypes and genetic characteristics of recent epidemics, the mechanism of infection and virus–host interactions, and its relationship to acute flaccid myelitis (AFM), in order to broaden our understanding of the biological features of EV-D68 and provide a basis for the development of effective antiviral agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It has also been found that the virus binds to the cellular receptor ICAM-5/telencephalin, which is expressed in dendrites and some neurons, to enter the cell [74, 75].”
From Viral meningitis: an overview (2021) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Kawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810
Kawai, T., & Akira, S. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.004 · Cited by 1,404 · cited 7×
“Xiang et al. [12] have reported that 3C(pro) cleaves TRIF at its amino- (Q312) and carboxyl-terminal (Q653) domains, leading to a loss of TRIF’s capacity to activate NF-κB and IFN-β signaling and thus helping enteroviruses to subvert host immune responses.”
BackgroundInfluentialInnate immunity to virus infection
Takeuchi, O., & Akira, S. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00737.x · Cited by 1,229 · cited 2×
“Enteroviruses are mainly recognized by three PRRs: Toll-like receptors (TLRs), retinoic acid-inducible gene I-like receptors (RLRs), and Nod-like receptors (NLRs) [34,35].”
BackgroundYan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 532 · cited 2×
“Enteroviruses are mainly recognized by three PRRs: Toll-like receptors (TLRs), retinoic acid-inducible gene I-like receptors (RLRs), and Nod-like receptors (NLRs) [34,35].”
BackgroundGreninger, A. L., Naccache, S. N., Messacar, K., Clayton, A., Yu, G., Somasekar, S., Federman, S., Stryke, D., Anderson, C., Yagi, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70093-9 · Cited by 390 · cited 4×
“This phenomenon suggests a potential for EV-D68 to induce nervous system disease [7], arousing widespread concern among health authorities and the public.”
BackgroundInfluentialA PROBABLE NEW HUMAN PICORNAVIRUS ASSOCIATED WITH RESPIRATORY DISEASE1
SCHIEBLE, J. H., FOX, V. L., & LENNETTE, E. H. (1967) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120693 · Cited by 345
Oberste, M. S., Maher, K., Schnurr, D., Flemister, M. R., Lovchik, J. C., Peters, H., Sessions, W., Kirk, C., Chatterjee, N., Fuller, S., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.79925-0 · Cited by 303 · cited 3×
“The most common clinical symptom of EV-D68 infection is respiratory illness [5].”
BackgroundInfluentialMidgley, C. M., Watson, J. T., Nix, W. A., Curns, A. T., Rogers, S. L., Brown, B. A., Conover, C., Dominguez, S. R., Feikin, D. R., Gray, S., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00335-5 · Cited by 239 · cited 2×
“According to the statistics of the US National Enterovirus Surveillance System (NESS), only 26 sporadic cases of EV-D68 were reported from 1970 to 2005 [2].”
BackgroundMethodThe major and minor group receptor families contain all but one human rhinovirus serotype
Uncapher, C. R., Dewitt, C. M., & Colonno, R. J. (1991) · Virology · doi:10.1016/0042-6822(91)90098-v · Cited by 239 · cited 1×
“Previous studies have shown that NA treatment reduces 90% of the attachment of EV-D68 to HeLa cells, indicating that sialic acid might be a potential receptor for EV-D68 [25].”
Result
Cited by
Kohil, A., Jemmieh, S., Smatti, M. K., & Yassine, H. M. (2021) · Archives of Virology · doi:10.1007/s00705-020-04891-1 · Cited by 164
Enterovirus D68 Antivirals: Past, Present, and Future
Hu, Y., Musharrafieh, R. G., Zheng, M., & Wang, J. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00120 · Cited by 91
“Rupintrivir (10) and AG7404 (11) act as ACS Infect Dis.”
BackgroundInfluentialMusharrafieh, R. G., Ma, C., Zhang, J., Hu, Y., Diesing, J. M., Marty, M. T., & Wang, J. (2019) · Journal of Virology · doi:10.1128/jvi.02221-18 · Cited by 72
The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses
Xu, N., Yang, J., Zheng, B., Zhang, Y., Cao, Y., Huan, C., Wang, S., Chang, J., & Zhang, W. (2020) · Journal of Virology · doi:10.1128/jvi.00204-20 · Cited by 70
“These human pathogens cause various contagious diseases, including hand, foot, and mouth disease (HFMD), encephalitis, myocarditis, acute flaccid myelitis (AFM), pneumonia, bronchiolitis, and so on (1–6).”
BackgroundEnterovirus D68 molecular and cellular biology and pathogenesis
Elrick, M. J., Pekosz, A. S., & Duggal, P. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100317 · Cited by 75
Understanding Enterovirus D68-Induced Neurologic Disease: A Basic Science Review
Hixon, A. M., Frost, J., Rudy, M. J., Messacar, K., Clarke, P., & Tyler, K. L. (2019) · Viruses · doi:10.3390/v11090821 · Cited by 67
“Acknowledgments: We thank Sun et al., 2019 and Zhang et al., 2018 for the use of their original figures.”
BackgroundEnteroviruses: epidemic potential, challenges and opportunities with vaccines
Jartti, M., Flodström‐Tullberg, M., & Hankaniemi, M. M. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01058-x · Cited by 61
Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease
Vogt, M. R., Fu, J., Kose, N., Williamson, L. E., Bombardi, R. G., Setliff, I., Georgiev, I. S., Klose, T., Rossmann, M. G., Hurst, B. L., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba4902 · Cited by 62
“Genetic diversification of EV-D68 has accelerated in recent years, resulting in the appearance of different viral clades with distinct genotypes designated A, B (with subclades B1, B2, and B3), C, and D (previously described as A2) (11).”
BackgroundGrizer, C. S., Messacar, K., & Mattapallil, J. J. (2024) · Frontiers in Virology · doi:10.3389/fviro.2024.1328457 · Cited by 57
Cheng, J., Gao, S., Zhu, C., Liu, S., Li, J., Kang, J. G., Wang, Z., & Wang, T. (2020) · Journal of Virology · doi:10.1128/jvi.02041-19 · Cited by 39
“respiratory symptoms were diagnosed with EV-D68 (1, 5, 6).”
BackgroundA Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68
Ma, C., Hu, Y., Zhang, J., Musharrafieh, R. G., & Wang, J. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00284 · Cited by 38
Zhang, C., Xu, C., Dai, W., Wang, Y., Liu, Z., Zhang, X., Wang, X., Wang, H., Gong, S., Cong, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23199-5 · Cited by 39
Hu, Y., Kitamura, N., Musharrafieh, R. G., & Wang, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00758 · Cited by 37
Combating SARS-CoV-2: leveraging microbicidal experiences with other emerging/re-emerging viruses
Ijaz, M. K., Sattar, S. A., Rubino, J. R., Nims, R. W., & Gerba, C. P. (2020) · PeerJ · doi:10.7717/peerj.9914 · Cited by 36
Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis
Tee, H. K., Zainol, M. I. B., Sam, I., & Chan, Y. F. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1851194 · Cited by 34
Freeman, M. C., Wells, A. I., Ciomperlik-Patton, J., Myerburg, M. M., Yang, L., Konopka‐Anstadt, J. L., & Coyne, C. B. (2021) · eLife · doi:10.7554/elife.66687 · Cited by 33
MFSD6 is an entry receptor for respiratory enterovirus D68
Liu, X., Li, H., Li, Z., Gao, D., Zhou, J., Ni, F., Yu, Q., Huang, Y., Tang, Y., Xue, L., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2024.12.015 · Cited by 31
Self-citationReckziegel, M., Weber-Osel, C., Egerer, R., Gruhn, B., Kubek, F., Walther, M., Wilhelm, S., Zell, R., & Krumbholz, A. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03878-9 · Cited by 23
“the development of acute flaccid myelitis and severe respiratory illness [69].”
BackgroundAntiviral Strategies Targeting Enteroviruses: Current Advances and Future Directions
Lee, M. F., Tham, S. K., & Poh, C. L. (2025) · Viruses · doi:10.3390/v17091178 · Cited by 17
“Nevertheless, similar to other human enteroviruses, EV-D68 can replicate in neurological tissues and has been classified as a high-risk pathogen, especially following a series of outbreaks in 2014 [28,29].”
Xu, B., Liu, M., Ma, S., Ma, Y., Liu, S., Shang, L., Zhu, C., Ye, S., & Wang, Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01025-21 · Cited by 16
Structure-Based Lead Optimization of Enterovirus D68 2A Protease Inhibitors
Tan, B., Liu, C., Li, K., Jadhav, P., Lambrinidis, G., Zhu, L., Olson, L. J., Tan, H., Wen, Y., Kolocouris, A., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00995 · Cited by 15
Boehr, A. K., Arnold, J. J., Oh, H. S., Cameron, C. E., & Boehr, D. D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010214 · Cited by 15
“RNA viruses represent some of the greatest threats to global health systems, including positive-strand RNA viruses like those belonging to the Flaviviridae (1) and Picornaviridae (2, 3) families.”
BackgroundRudy, M. J., Frost, J., Clarke, P., & Tyler, K. L. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-22 · Cited by 15
“There are currently no proven effective antiviral therapies for treatment of AFM, nor is there a vaccine (3).”
BackgroundViruses Like Sugars: How to Assess Glycan Involvement in Viral Attachment
Mathez, G., & Cagno, V. (2021) · Microorganisms · doi:10.3390/microorganisms9061238 · Cited by 14
“Successive studies have shown that some strains can replicate in neural cells in contrast with the original ones [53,80,81].”
ResultDiscovery and Optimization of Quinoline Analogues as Novel Potent Antivirals against Enterovirus D68
Li, X., Li, Y., Fan, S., Cao, R., Li, X., He, X., Li, W., Xu, L., Cheng, T., Li, H., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01311 · Cited by 13
Li, L., Wang, M., Chen, Y., Hu, T., Yang, Y., Zhang, Y., Bi, G., Wang, W., Liu, E., Han, J., et al. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107510 · Cited by 13
Molecular typing of enteroviruses: comparing 5′UTR, VP1 and whole genome sequencing methods
Gulholm, T., Yeang, M., Nguyen, I., Andrews, P. I., Balgahom, R., Beresford, R., Branley, J. M., Briest, R. C., Britton, P. N., Burrell, R., et al. (2022) · Pathology · doi:10.1016/j.pathol.2022.03.013 · Cited by 12
Senpuku, K., Kataoka-Nakamura, C., Kunishima, Y., Hirai, T., & Yoshioka, Y. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.03.016 · Cited by 11
Licochalcone A regulates viral IRES activity to inhibit enterovirus replication
Chuang, Y.-T., Lin, Y., & Lin, J. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105755 · Cited by 10
Rudy, M. J., Wilson, C. J., Hinckley, B., Baker, D. C., Royal, J. M., Hoke, M., Brennan, M. B., Vogt, M. R., Clarke, P., & Tyler, K. L. (2025) · mBio · doi:10.1128/mbio.03906-24 · Cited by 10
“There are currently no approved antiviral therapies for treatment of AFM, nor is there an available EV-D68 vaccine (7).”
Alsahag, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-95163-y · Cited by 10
Yang, Q., Li, H., Li, Z., Yang, J., Zhang, Z., Zhang, L., Guo, H., & Wei, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1118933 · Cited by 9
“Previous studies have found that sialic acid on the host cytomembrane facilitates EV-D68 infection (4).”
ResultLi, Q., Chen, X., Ai, J., Li, L., Li, C., Zhu, Y., Wang, R., Duan, Y., Zhang, M., & Xie, Z. (2023) · Archives of Virology · doi:10.1007/s00705-023-05823-5 · Cited by 10
“Although EV-D68 has not been detected in cerebrospinal fluid (CSF) from AFP patients [8], it was detected in CSF from two patients with aseptic meningitis and meningoencephalitis in Spain [13].”
BackgroundAustralian National Enterovirus Reference Laboratory annual report, 2022
Kaye, M. B., Hobday, L. K., Ibrahim, A., Bruggink, L. D., & Thorley, B. R. (2023) · Communicable Diseases Intelligence · doi:10.33321/cdi.2023.47.35 · Cited by 9
Australian National Enterovirus Reference Laboratory annual report, 2023
Kaye, M. B., Hobday, L. K., Ibrahim, A., Bruggink, L., & Thorley, B. R. (2025) · Communicable Diseases Intelligence · doi:10.33321/cdi.2025.49.013 · Cited by 9
Global Evolution and Transmission Dynamics of Enterovirus D68
Xiao, M., Han, Z., Ma, X., Ji, T., Yan, D., Wang, D., Zhu, S., Lu, H., Cong, R., Wang, X., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70497 · Cited by 8
Mengual‐Chuliá, B., Tamayo‐Trujillo, R., Mira‐Iglesias, A., Cano, L., Garcia, S., Ferrús, M. L., Puig‐Barberà, J., Díez‐Domingo, J., López‐Labrador, F. X., & the VAHNSI network (2024) · Journal of Medical Virology · doi:10.1002/jmv.29810 · Cited by 8
Chen, H., Huang, M., Hou, B., Liu, Z., Tan, R., Cui, L., Wang, T., & Wang, Z. (2025) · Journal of Virology · doi:10.1128/jvi.00163-25 · Cited by 7
“Research has shown that 3C pro and 2A pro of enterovirus are important molecules in the innate immune evasion strategy (19).”
Senpuku, K., Kunishima, Y., Taniguchi, K., Ito, T., Hirai, T., Nakamura, T., Kataoka-Nakamura, C., & Yoshioka, Y. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127314 · Cited by 7
Lerner, A. M., DeRocco, A. J., Yang, L. C., Robinson, D. A., Eisinger, R. W., Bushar, N. D., Nath, A., & Erbelding, E. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1432 · Cited by 7
“Approved antiviral treatments for enterovirus infection do not currently exist [24].”
BackgroundMessacar, K., Vogt, M. R., Asturias, E. J., & Abzug, M. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00023-2 · Cited by 7
Deng, H., Li, Y., He, X., Wang, H., Wang, S., Zhang, H., Zhu, J., Gu, L., Li, R., & Wang, G. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29831 · Cited by 6
“22 29 Prevention should concentrate on both intestinal and respiratory”
Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy
Alekseeva, O. N., Hoa, L. T. K., Vorobyev, P. O., Кочетков, Д. В., Gumennaya, Y. D., Naberezhnaya, E. R., Chuvashov, D. O., Ivanov, A. V., Chumakov, P. M., & Lipatova, A. V. (2024) · Cancers · doi:10.3390/cancers16183139 · Cited by 6
Australian National Enterovirus Reference Laboratory annual report, 2021
Kaye, M. B., Garcia-Clapes, A., Hobday, L. K., Ibrahim, A., & Chanthalavanh, P. (2022) · Communicable Diseases Intelligence · doi:10.33321/cdi.2022.46.55 · Cited by 6
Li, H., Huang, Y., Yang, Q., Zhang, Z., Shen, S., Guo, H., & Wei, W. (2024) · Journal of Virology · doi:10.1128/jvi.00434-24 · Cited by 5
“However, reports indicate that the EV-D68 virus has now been detected in various regions worldwide and poses a potential risk for widespread epidemics (33).”
ResultFu, H., Si, J., Xu, L., Tang, X., He, Y., Lü, N., Li, H., Li, A., Gao, S., & Yang, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1081237 · Cited by 5
“org has been associated with only a few instances of respiratory illness (HolmHansen et al., 2016; Xiang and Wang, 2016; Messacar et al., 2016b; Sun et al., 2019).”
BackgroundRai, A., Ammi, Z., Anes-Boulahbal, D. L., Assadi, A. A., Amrane, A., Baaloudj, O., & Mouni, L. (2024) · Viruses · doi:10.3390/v16020170 · Cited by 7
“The genus Enterovirus (EV), of the family Picornaviridae, consists of small, non-enveloped, single-stranded ribonucleic acid (RNA) viruses (27 to 30 nm particles) of positive polarity [4–8] HEVs, including four species (HEV A, B, C and D) and grouping more than 120 serotypes [5,9–11].”
BackgroundGenetic analysis of Enterovirus D68 associated with pneumonia in children from South India
Sanjay, R., Sabeena, S., Robin, S., John, S. T., Jayakrishnan, M. P., Suresh, E. K. K., Michael, C. J., Aswathyraj, S., Joseph, J., Sheik, S., et al. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001356 · Cited by 5
Nafisa, S., Paul, P., & Sovani, M. P. (2021) · Cureus · doi:10.7759/cureus.15625 · Cited by 5
Rational design and in vivo validation of capsid inhibitors for enterovirus D68
Li, K., Rudy, M. J., Klose, T., Tan, H., Wu, X., Demssie, H., Anderson, J. S., Jadhav, P., Zhang, Q.-Y., Clarke, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69351-x · Cited by 4
Clinical Presentation of Enterovirus D68 in a Swiss Pediatric University Center
Ott, C., Dutilh, G., Reist, J., Bingisser, R. M., Egli, A., & Heininger, U. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004503 · Cited by 4
Insights Into Enterovirus D68 Immunology: Unraveling the Mysteries of Host‐Pathogen Interactions
Naeem, A., Bello, M. B., & Bosaeed, M. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70117 · Cited by 4
Chuang, K., Pan, S., Chiang, B., Chen, S.-L., Pan, M., Chen, Y., Lin, C., Pan, C., Lin, J., & Lin, Y. (2025) · Phytotherapy Research · doi:10.1002/ptr.8496 · Cited by 4
“Given that both hSCARB2 and hICAM-5 are highly expressed in the central nervous system (Sun et al. 2019), Pte may relieve neu-rotropism during enteroviral infection by restricting the access of viral binding sites to these receptors.”
InfluentialLemos, E. R. S. D., Villar, L. M., Leon, L. A. A., Guimarães, M. L., Teixeira, S. L. M., & Paula, V. S. D. (2023) · Editora FIOCRUZ eBooks · doi:10.7476/9786557082119 · Cited by 10
Australian National Enterovirus Reference Laboratory annual report, 2020
Kaye, M. B., Garcia-Clapes, A., Hobday, L. K., Ibrahim, A., Chanthalavanh, P., Bruggink, L. D., & Thorley, B. R. (2021) · Communicable Diseases Intelligence · doi:10.33321/cdi.2021.45.56 · Cited by 4
Moss, D. L., Cheng, J., Krug, P. W., Paine, A. C., Fisher, B. E., Henry, A. R., Roberts-Torres, J., Johnston, T. S., Smith, S. M., Pletnev, S. V., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aec5446 · Cited by 3
Yoshida, K., Muramatsu, M., & Shimizu, H. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08429-z · Cited by 3
“Currently, clades A–D are identified as the circulating subtypes of EV-D68 [3, 4], and clades A, B, and C are predominantly detected in Japan [5, 6].”
BackgroundAcute flaccid myelitis outbreak through 2016–2018: A multicenter experience from Turkey
Unver, O. I., Türkdoğan, D., Güler, S., Kipoğlu, O., Güngör, M., Paketçi, C., Çarman, K. B., Öztürk, G., Genç, H. M., Özkan, M., et al. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.10.011 · Cited by 3
Development of RT-qPCR for quantification of human enterovirus D68 in vitro
Ørstenvik, H. L., Tveten, A., & Cao, Y. (2023) · MethodsX · doi:10.1016/j.mex.2023.102234 · Cited by 2
“However, the virus also causes infection in the gastrointestinal tract and can result in neurological complications [11 , 10] .”
BackgroundInsights into the molecular evolution of enterovirus D68
Wolf, J. M. (2023) · Archives of Virology · doi:10.1007/s00705-023-05894-4 · Cited by 2
“It is important to note that while EV-D68 can cause severe respiratory illness, most individuals who contract the virus experience mild symptoms and recover without complications [ 5 , 7, 10].”
BackgroundBeyond respiratory syncytial virus and rhinovirus
Abdelkader, S., Voladri, D. R., & Kennedy, J. L. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.06.012 · Cited by 2
Australian National Enterovirus Reference Laboratory annual report, 2024
Kaye, M. B., Hobday, L. K., Bruggink, L. D., McKenzie, J., Nong, Y., & Thorley, B. R. (2025) · Communicable Diseases Intelligence · doi:10.33321/cdi.2025.49.047 · Cited by 1
Li, K., Ni, J., Fan, G., & Wang, J. (2026) · JACS Au · doi:10.1021/jacsau.6c00039 · Cited by 1
An RNA-to-RNA pipeline for rapid antiviral antibody development
Hodge, E. A., Archer, J. F., Anderson, J. S., Warner, N. L., Tremblay, J., Klose, T., Park, S., Hinkley, T. C., Khandhar, A. P., Kuhn, R., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.021 · Cited by 1
Enterovirus D68: molecular biological characteristics, features of infection
Zverev, V. V., & Алексеевна, Н. Н. (2019) · MediAl · doi:10.21145/2225-0026-2019-2-40-54 · Cited by 1
“Отмечена совместная циркуляция представителей различных подтипов, при этом субтип C является наименее распространенным [26].”
InfluentialBaştemur, M., Göçmen, R., Parlak, Ş., Yüksel, D., Arslan, E. A., Ökten, A. İ., İşcan, A., Ekici, B., & Anlar, B. (2020) · Journal of Child Neurology · doi:10.1177/0883073820911737 · Cited by 1
Anwar, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00154-3 · Cited by 1
A Fluorogenic Labeling of Live VirusesPreprint
Zheng, B., Li, X., Xie, S., Wang, S., Lai, W., Zhou, Z., Liu, Q., Yang, Y., Hou, B., Ni, W., et al. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-bqkwt
Enterovirus D68 infection in children with acute lower respiratory tract infection in ChinaPreprint
Li, Q., Chen, X., Ai, J., Li, L., Li, C., Zhu, Y., Wang, R., Duan, Y., Zhang, M., & Xie, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1401303/v2
Suresh, A. J., & Dass, R. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91814-5.00015-5
Leon, L. A. A., Lima, L. R. P., Lanzarini, N. M., de Almeida, N. A. A., & de Paula, V. S. (2023) · Editora FIOCRUZ eBooks · doi:10.7476/9786557082119.0008
Respiratory Viruses and Atypical Bacteria
McNamara, P. S., van Doorn, H. R., Adetifa, I., & Nokes, D. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00025-7 · Cited by 1
Enterovirus D68: Epidemiology of a Virus that Causes Pediatric Infectious Disease
Wolf, J. M. (2023) · Clinical & Biomedical Research · doi:10.22491/2357-9730.133377
“If EV-D68 outbreaks are occurring or there is a high prevalence of cases in the area, it increases the likelihood of EV-D68 infection in symptomatic individuals 10,40-44 .”
BackgroundInfluentialНОВЫЕ ИССЛЕДОВАНИЯ НОВОЙ ЭПОХИ. ОПЫТ ТЕОРЕТИЧЕСКОГО И ЭМПИРИЧЕСКОГО АНАЛИЗА
Lugansky, W. I., Serezhnikova, R. K., университет», Г. В. М. «. Г.-Т., Неверкович, С. Д., «ГЦОЛИФК», Р. У. С., Bystritskaya, E. V., туризма», Г. А. О. У. В. О. «. Г. У. С. И., Kuznetsova, S. V., туризма», Г. А. О. У. В. О. «. Г. У. С. И., Vostrikova, T. I., et al. (2024) · ICSP «NEW SCIENCE» eBooks · doi:10.46916/02092024-1-978-5-00215-451-7
Trends in Meningitis Prevalence and the Need for Molecular Diagnosis
Baig, M. S., Rizvi, A. H., Varma, S., Ghaus, K., Arzoo, A., Saloni, & Anas, M. (2025) · Medical virology · doi:10.1007/978-981-96-7097-0_8 · Cited by 1
Investigation of antiviral activity of greek honeys against enterovirus D68
Δημητριάδου, Μ. Π. (2020) · University of Thessaly Institutional Repository (University of Thessaly)
Luparev, A. R., Tolokonceva, A. A., Polyakova, V. A., Евгеньевна, Д. Е., & Shipulin, G. A. (2025) · Laboratory Service · doi:10.17116/labs20251404113
Prevention of Enterovirus Infection and New Treatment Methods
Žiaugaitė, A. (2024) · Lithuanian University of Health Sciences
Entérovirus D68 : analyse épidémiologique & génomique
Duval, M. (2022) · theses.fr (ABES) · doi:10.70675/d9667b88z28f8z4244zadb5z4bd1c24522e4 · Cited by 1
Fong, Y. D., Yogarajah, T., Khoo, X. W., Chan, Y. S., Mohameed, J. B. H., Neo, A., Yi, B., & Chu, J. J. H. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.052
“Severe cases of infection develop into pneumonia, respiratory failure, or acute flaccid myelitis, a grave condition of the spinal cord that could result in paralysis 4 .”
Sethy, B., Nguyen, M. T., Narwanti, I., Hsieh, C.-F., Chen, C.-L., Cai, J.-Y., Pei-Wen, H., Liou, J.-P., & Horng, J. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110697
Metadata
- Authors
- Sun, J., Hu, X.-Y., & Yu, X.-F.
- Affiliations
- Zhejiang University (CN)
- Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), School of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang, China
- Corresponding author
- Yu, Xiao-Fang
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2019-05-29
- Volume
- 11
- Issue
- 6
- Pages
- 490
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC6631698
- OpenAlex
- W2947138230
- Cited by
- 81
- References
- 71
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 9 · 2023: 15 · 2022: 7 · 2021: 12 · 2020: 15 · 2019: 5
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81772169)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Keywords
- enterovirus D68, acute flaccid myelitis, severe respiratory disease, host-virus interaction, viral pathogenesis, genotypes, genetic characteristics, epidemics, antiviral drug discovery, vaccines, children
- MeSH terms
- Host Microbial Interactions, Disease Outbreaks, Enterovirus Infections, Humans, Respiratory Tract Infections, United States, Enterovirus D, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.